Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study
Archives of Cardiovascular Diseases Supplements · 2018
DOI: 10.1016/j.acvdsp.2017.11.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Cardiovascular Diseases Supplements, 2018. Verfasst von P. Deharo und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Deharo, P., Quilci, J., Bassez, C., Bonnet, G., Lambert, M., Morange, P., Alessi, M., Fourcade, L., Bonnet, J., & Cuisset, T. (2018). Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study. Archives of Cardiovascular Diseases Supplements. https://doi.org/10.1016/j.acvdsp.2017.11.010
Vancouver
Deharo P, Quilci J, Bassez C, Bonnet G, Lambert M, Morange P, et al. Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study. Archives of Cardiovascular Diseases Supplements. 2018. doi:10.1016/j.acvdsp.2017.11.010
BibTeX
@article{Deharo2018,
author = {Deharo, P. and Quilci, J. and Bassez, C. and Bonnet, G. and Lambert, M. and Morange, P. and Alessi, M.C. and Fourcade, L. and Bonnet, J. and Cuisset, T.},
title = {Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study},
journal = {Archives of Cardiovascular Diseases Supplements},
year = {2018},
doi = {10.1016/j.acvdsp.2017.11.010}
}
EUVIMED